ArrePath
PrivateLast Round
VC Round
Jun 23, 2025
Total Funding Raised
$24.97M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
ArrePath is a biotechnology company that operates a drug discovery platform intended to develop antimicrobial resistance therapies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Medical Imaging
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ArrePath Comparables
Compare ArrePath with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stoked Bio Inc. | 86% | |
| Phare Bio | 79% | |
| Terray Therapeutics | 76% | |
ArrePath Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 23, 2025 | ||||
| Grant | Apr 2, 2025 | ||||
| Grant | Nov 19, 2024 | ||||
| Seed | Mar 3, 2022 |
ArrePath Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| PTX Capital | Seed |
| Nor'easter Ventures | VC Round, Seed |
| Boehringer Ingelheim | VC Round, Seed |
| PACE (Pathways to Antimicrobial Clinical Efficacy) | Grant |
| CARB-X | Grant |
| Viva BioInnovator | Seed |
| Ab Magnitude Ventures Group | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 30% MoM.
- Jul 20, 2026
Open roles increased to 15, representing 88% of headcount.
ArrePath Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ArrePath's valuation, stock price, and market status.